Skip to content
FIND A HEALTH VALLEY ACTOR

ADC Therapeutics signs multi-million dollar licensing agreement with Sobi

ADC Therapeutics

The swiss and the Swedish companies partner for the development and commercialization of ZYNLONTA®, a drug for hematologic and solid tumors   ADC Therapeutics SA has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (Sobi®) for the development and commercialization of ZYNLONTA® for all hematologic and solid tumor indications outside of the…

Read More

Gnubiotics gets a CHF 1.4 million Innosuisse Grant

Gnubiotics

The biotech company evaluates the effects of glycopeptides on solid tumors   Gnubiotics Sciences, a biotech company pioneering the discovery and development of immunomodulatory glycopeptides based in Biopôle, announced that the Swiss Innovation Agency (Innosuisse) will support a research collaboration with the University Hospital Zürich to accelerate the development of Gnubiotics’ GLAAD technology in a…

Read More

CHF 4 million for b-rayZ AG, a startup fighting breast cancer

b-ray Z

The Tech4Eva alumni and University Hospital Zurich (USZ) uses AI for faster and better breast cancer diagnostics     b-RayZ AG has closed an oversubscribed Series A financing round worth over four million Swiss francs with leading investors in the Life Sciences and IT sector. The financing round was led by LifeCare Partners, Protagon AG and…

Read More

KBI Biopharma SA and Selexis SA inaugurated a new facility in Geneva

Selexis - kbi

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development and manufacturing services facility in Plan-les-Ouates in Geneva, Switzerland. The ~8 700 m2 integrated KBI/Selexis state-of-the-art facility builds upon the companies’ existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian cell…

Read More

Scaling Up Sales

scaling up sales

From the idea to the market, grow your business with a marketing and sales programme   Scaling Up Sales is a program supported by the Service de la promotion de l’économie et de l’innovation (SPEI) of the Canton of Vaud, in partnership with Innovaud and the Fondation pour l’Innovation Technologique (FIT). This program supports SMEs…

Read More

Vaud invests CHF 178 Million in Life Sciences

Vaud Investments Life Sciences

To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne in Life Sciences, the State Council is requesting five investment credits totaling CHF 178.71 million from the Grand Council.   In Dorigny, these investments would allow the construction of a life sciences building and, in…

Read More

Supervene: growing humain vein tissues

CSEM and Clexbio Team

ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins in the lab. The joint project has received CHF 2 million in funding from the Research Council of Norway.   Severe chronic venous insufficiency (CVI) is a debilitating disease afflicting millions of people around the…

Read More

Geneva researcher wins European Inventor’s Award

Madiha Derouazi (right) and Elodie Belnoue (left)

Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded for her therapeutic vaccines against cancer.   The European Patent Office (EPO) awarded the two researchers the European Inventor Award 2022 in the “SME” category at a ceremony in Munich on Tuesday. The teammates have…

Read More

ten23health is building a new facility in Visp

ten23health

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a former Swissfillon site to install its production facility. In March 2022, a first 1,000 m2 expansion was announced. The new 5,000 m2 facility will include sterile manufacturing lines plus laboratories, offices and technical areas across…

Read More

Ecotope, the new EPFL Innovation Park’s project

Ecotope 1

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together startups, researchers and outside companies. The Canton of Vaud is the project’s main partner.   The EPFL Innovation Park is already home to over 150 startups and 30 large companies employing over 2,600 people. In…

Read More